These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 7177508)

  • 1. The copper hypothesis of schizophrenia: a review.
    Bowman MB; Lewis MS
    Neurosci Biobehav Rev; 1982; 6(3):321-8. PubMed ID: 7177508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Further investigations on ceruloplasmin in hepatolenticular degeneration and on the effect of copper on oxidase activity of ceruloplasmin.
    Wald I; Galewicz A; Górska D
    Pol Med J; 1972; 11(3):733-9. PubMed ID: 5047986
    [No Abstract]   [Full Text] [Related]  

  • 3. Serum ceruloplasmin levels in healthy persons and in certain pathologic conditions.
    Lyko J
    Acta Med Pol; 1967; 8(3):269-77. PubMed ID: 6062192
    [No Abstract]   [Full Text] [Related]  

  • 4. [Plasma non-ceruloplasmin copper in hepatocerebral dystrophy (criterion for the diagnosis and evaluation of cuprogogue therapy)].
    Botvinnik VS; Lekar' PG; Makarova VA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1981; 81(3):334-7. PubMed ID: 7257674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Metabolism of ceruloplasmin and copper in the blood in Wilson's disease].
    Kanai M; Nomoto S; Tsukagoshi H; Shindo M
    Rinsho Byori; 1974 Oct; 22(10 Suppl):191. PubMed ID: 4475793
    [No Abstract]   [Full Text] [Related]  

  • 6. Wilson's disease and mental disturbances.
    Vitorovic S; Lieina M
    Can J Psychiatry; 1996 Mar; 41(2):132-3. PubMed ID: 8705963
    [No Abstract]   [Full Text] [Related]  

  • 7. Aberrance of Serum Zinc and Free Copper Level in Wilson Disease.
    Iorio R; Ranucci G
    J Pediatr Gastroenterol Nutr; 2016 May; 62(5):e46. PubMed ID: 26863385
    [No Abstract]   [Full Text] [Related]  

  • 8. Aberrance of Serum Zinc and Free Copper Level in Wilson Disease.
    Sintusek P; Dhawan A
    J Pediatr Gastroenterol Nutr; 2016 May; 62(5):e46. PubMed ID: 26690865
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of the blood serum from subjects with hepatolenticular degeneration on the ceruloplasmin activity in the serum of normal and schizophrenic subjects].
    Puzyński S; Kalinowski A
    Neurol Neurochir Psychiatr Pol; 1966 Aug; 16(8):885-90. PubMed ID: 5969522
    [No Abstract]   [Full Text] [Related]  

  • 10. [Features of the course and disorders of copper and ceruloplasmin metabolism in hepatolenticular degeneration].
    Davidenkova EF; Neĭfakh SA; Butomo IV; Mashkov BA; Lapchenkov VI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1967; 67(7):982-90. PubMed ID: 5598796
    [No Abstract]   [Full Text] [Related]  

  • 11. Changes in serum copper and PPD-oxidase in different diseases. II. Comparative studies in Wilson's disease schizophrenia and Parkinsonism.
    Chitre VS; Punekar BD
    Indian J Med Res; 1970 May; 58(5):563-73. PubMed ID: 5473254
    [No Abstract]   [Full Text] [Related]  

  • 12. [Ceruloplasmin in hepatolenticular degeneration and the effect of copper on oxidative activity of ceruloplasmin].
    Wald I; Galewicz A; Górska D
    Neurol Neurochir Pol; 1971; 5(5):622-9. PubMed ID: 4258660
    [No Abstract]   [Full Text] [Related]  

  • 13. [Hepatocerebral degeneration (Wilson's disease). Demonstration of the clinical picture and demonstration of own case].
    Rosenberger K
    Nervenarzt; 1973 Sep; 44(9):484-7. PubMed ID: 4750027
    [No Abstract]   [Full Text] [Related]  

  • 14. ENDOGENOUS COPPER CLEARANCE IN WILSON'S DISEASE: A STUDY OF THE MODE OF ACTION OF PENICILLAMINE.
    WALSHE JM
    Clin Sci; 1964 Jun; 26():461-9. PubMed ID: 14191274
    [No Abstract]   [Full Text] [Related]  

  • 15. Plasma copper, iron, ceruloplasmin and ferroxidase activity in schizophrenia.
    Wolf TL; Kotun J; Meador-Woodruff JH
    Schizophr Res; 2006 Sep; 86(1-3):167-71. PubMed ID: 16842975
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Abnormalities of the physiology of copper in Wilson's disease. I. The whole-body turnover of copper.
    O'Reilly S; Strickland GT; Weber PM; Beckner WM; Shipley L
    Arch Neurol; 1971 May; 24(5):385-90. PubMed ID: 5554862
    [No Abstract]   [Full Text] [Related]  

  • 17. Wilson disease.
    Houwen RH; van Hattum J; Hoogenraad TU
    Neth J Med; 1993 Aug; 43(1-2):26-37. PubMed ID: 8232692
    [No Abstract]   [Full Text] [Related]  

  • 18. Exchange of ceruloplasmin copper with ionic Cu64 with reference to Wilson's disease.
    SCHEINBERG IH; MORELL AG
    J Clin Invest; 1957 Aug; 36(8):1193-201. PubMed ID: 13463081
    [No Abstract]   [Full Text] [Related]  

  • 19. [Pathobiochemistry of Wilson's disease].
    Biesold D; Lössner J; Bachmann H; Zotter J
    Z Med Lab Diagn; 1982 Oct; 23(5):278-84. PubMed ID: 7180077
    [No Abstract]   [Full Text] [Related]  

  • 20. Studies on copper metabolism. XIV. Copper, ceruloplasmin and oxidase activity in sera of normal human subjects, pregnant women, and patients with infection, hepatolenticular degeneration and the nephrotic syndrome.
    MARKOWITZ H; GUBLER CJ; MAHONEY JP; CARTWRIGHT GE; WINTROBE MM
    J Clin Invest; 1955 Oct; 34(10):1498-508. PubMed ID: 13263429
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.